“…Recently, Ko et al (2009) (Figure 6) addressed the role of prefrontal DA during set-shifting tasks in healthy subjects by using [ 11 C]FLB 457, a chemical compound with a greater affinity (Kd ÂŒ 20 nM) for D2 receptors, which allows evaluation of extrastriatal DA release (Aalto et al, 2005a;Olsson et al, 1999;Sudo et al, 2001). Olsson et al (2004) had previously shown that [ 11 C]FLB 457 BP calculated by simplified reference tissue model (Gunn et al, 1997;Lammertsma and Hume, 1996;Sudo et al, 2001) may provide a reasonable estimate of receptor densities in different extrastriatal areas (for example, in cingulate cortex, frontal cortex, thalamus, and temporal cortex), consistent with postmortem studies using [ 125 I]epidepride (Kessler et al, 1993). Similarly, [ 11 C]FLB 457 has been shown to be sensitive in detecting changes in extrastriatal endogenous DA concentration in non-human primates (Chou et al, 2000) and in humans (Aalto et al, 2005a, b;Hagelberg et al, 2004;Montgomery et al, 2007 (Narendran et al, 2009).…”